Insmed Incorporated

Insmed Incorporatedverified

INSM

Price:

$70.53

Market Cap:

$12.62B

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated ...[Read more]

Industry

Biotechnology

IPO Date

2000-06-01

Stock Exchange

NASDAQ

Ticker

INSM

The ROE as of December 2024 (TTM) for Insmed Incorporated (INSM) is 1.26%

According to Insmed Incorporated’s latest financial reports and current stock price. The company's current ROE is 1.26%. This represents a change of -789.94% compared to the average of -182.54% of the last 4 quarters.

Insmed Incorporated (INSM) Historical ROE (quarterly & annually)

How has INSM ROE performed in the past?

The mean historical ROE of Insmed Incorporated over the last ten years is -103.49%. The current 1.26% ROE has changed -1316.91% with respect to the historical average. Over the past ten years (40 quarters), INSM's ROE was at its highest in in the September 2022 quarter at 437.75%. The ROE was at its lowest in in the June 2024 quarter at -774.41%.

Quarterly (TTM)
Annual

Average

-103.49%

Median

-101.54%

Minimum

-547.50%

Maximum

225.83%

Insmed Incorporated (INSM) ROE by Quarter and Year

Discovering the peaks and valleys of Insmed Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 417.04%

Maximum Annual ROE = 225.83%

Minimum Annual Increase = -141.25%

Minimum Annual ROE = -547.50%

Quarterly (TTM)
Annual
YearROEChange
2023225.83%-141.25%
2022-547.50%417.04%
2021-105.89%-0.66%
2020-106.60%9.67%
2019-97.20%-37.58%
2018-155.70%191.82%
2017-53.36%-53.24%
2016-114.11%200.94%
2015-37.92%-10.80%
2014-42.50%8.64%

Insmed Incorporated (INSM) Average ROE

How has INSM ROE performed in the past?

The current ROE of Insmed Incorporated (INSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-142.52%

5-year avg

-126.27%

10-year avg

-103.49%

Insmed Incorporated (INSM) ROE vs. Peers

How is INSM’s ROE compared to its peers?

Insmed Incorporated’s ROE is less than Ascendis Pharma A/S (212.63%), greater than Apellis Pharmaceuticals, Inc. (-103.92%), greater than BeiGene, Ltd. (-25.12%), greater than Akero Therapeutics, Inc. (-32.52%), greater than Blueprint Medicines Corporation (-47.66%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Avidity Biosciences, Inc. (-27.66%), greater than Revolution Medicines, Inc. (-33.67%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than SpringWorks Therapeutics, Inc. (-48.21%), greater than Keros Therapeutics, Inc. (-41.74%), greater than Janux Therapeutics, Inc. (-10.46%), less than Fennec Pharmaceuticals Inc. (31.99%), greater than Edgewise Therapeutics, Inc. (-26.83%), less than Harmony Biosciences Holdings, Inc. (23.16%), less than Halozyme Therapeutics, Inc. (156.40%), less than Agios Pharmaceuticals, Inc. (70.20%), greater than Ultragenyx Pharmaceutical Inc. (-187.12%),

Build a custom stock screener for Insmed Incorporated (INSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insmed Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Insmed Incorporated (INSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Insmed Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Insmed Incorporated's ROE?

How is the ROE calculated for Insmed Incorporated (INSM)?

What is the highest ROE for Insmed Incorporated (INSM)?

What is the 3-year average ROE for Insmed Incorporated (INSM)?

What is the 5-year average ROE for Insmed Incorporated (INSM)?

How does the current ROE for Insmed Incorporated (INSM) compare to its historical average?